Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Vancomycin Study in Multiple Sclerosis (MS) — Stella

Home/Multiple Sclerosis/Vancomycin Study in Multiple Sclerosis (MS)

View on ClinicalTrials.gov

Recruiting

Back to Multiple Sclerosis trials

Vancomycin Study in Multiple Sclerosis (MS)

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai, New York, New York

Key details

Phase

Early testing

Sponsor

Icahn School of Medicine at Mount Sinai

Collaborators

Doris Duke Charitable Foundation

Enrollment target

~12 participants

Started

January 2023

Primary completion

March 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 50 Years

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.